Clinical Trial Update: Azithromycin Dose and PPROM Treatment: a Pilot Randomized Controlled Trial [Phase 4]

View source ↗

Summary

A Phase 4 pilot randomized controlled trial evaluating azithromycin dose strategies for treating preterm premature rupture of membranes (PPROM) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Preterm Premature Rupture of Membranes

Drugs mentioned

• Azithromycin (azithromycin)

Snippet

Sponsor: Thomas Jefferson University | Conditions: Preterm Premature Rupture of Membrane | Phase 4 | Status: COMPLETED